Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR versus mirtazapine for sleep in major depression
2008-003331-20Phase 2Terminated
- Sponsor
- Technical University of Munich
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of quetiapine and mirtazapine in major depressive disorder (MDD) (2 arms), sponsored by Technical University of Munich. Primary endpoint: Change in polysomnographically measured sleep efficiency. Started Jul 2008; status: terminated.
02
Drugs
quetiapinemirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-003331-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003331-20.